Esophageal cancer, specifically squamous cell carcinoma, is tough to beat. Doctors usually treat it with a combo of chemotherapy, radiation, and surgery. But, even with this approach, the results aren't great. So, researchers are always looking for ways to improve treatment. One promising area is i
In the world of medicine, tiny details can make a big difference. One such detail is the level of a substance called interleukin-6 in the blood after surgery. This substance is a marker of inflammation, and it plays a crucial role in how well a person recovers from esophageal cancer surgery. Esopha
A seasoned firefighter from Baltimore is now fighting a different kind of fire. He was diagnosed with stage 4 esophageal cancer on Valentine's Day. This is a type of cancer that starts in the esophagus, the tube that carries food from the mouth to the stomach. The firefighter, Steve Dorsey
In Japan, the number of people with Barrett's esophageal adenocarcinoma (BEA) has been climbing. This is due to several factors. Fewer people are getting infected with Helicobacter pylori. Plus, diets are becoming more Westernized. And obesity rates are going up. But finding BEA in someone in their
Esophageal cancer is a serious illness that starts in the tube connecting the mouth to the stomach. It's not easy to treat, and doctors are always searching for better ways to help patients. One approach is using neoadjuvant treatment, which involves giving treatment before the main procedure, like
Cancer in the stomach and esophagus has been tough to beat, but new treatments are changing that. Still, these cancers cause unique nutrition problems. Before, during, and after treatments, patients have special needs. This is where nutrition steps in, becoming a crucial part of their care. Doctors
Immunotherapy has been making waves in the treatment of esophageal cancer, especially when used after initial chemoradiation. But what about patients with esophageal squamous cell carcinoma who've had a different combo—immunochemotherapy before surgery? Does adjuvant immunotherapy (AIT) still matter
Have you ever wondered what factors influence the rise or fall of esophageal cancer rates? Well, let's dive into a study that delved deep into this question, focusing on Kuwait from 1980 to 2019. This research aimed to figure out how age, time, and the generation you're born into can affect your cha
Esophageal cancer (EC) patients undergo significant changes during and after their treatment with chemoradiotherapy. These changes include shifts in body mass index (BMI), performance status, nutrition status, symptom distress, and physical fitness. A recent study explored how these factors evolve o
Esophageal squamous cell carcinoma (ESCC) is a growing concern globally, with limited effective treatments available. There’s a drug called ivermectin that could potentially change the game. Usually used against parasites, ivermectin has shown promise in slowing down cancer growth in lab studies. Sc
